We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,495 results
  1. Determination of Paclitaxel Solubility and Stability in the Presence of Injectable Excipients

    Due to poor aqueous solubility of paclitaxel, cremophor is one of the excipients used to improve solubility in Taxol while it is responsible for a...

    Ali Sadeghi-Oroumiyeh, Hadi Valizadeh, Parvin Zakeri-Milani in Pharmaceutical Chemistry Journal
    Article 02 December 2021
  2. Bruceine D Sensitizes Human Ovarian Cancer Cells to Paclitaxel Through JNK and STAT3 Signal Regulation

    Exploring novel regimens is essential to ensure the efficacy of paclitaxel-based chemotherapy in epithelial ovarian cancer. Brucea javanica (L.)...

    Zhipeng Yan, Zhihong **, ... Caixia Shi in Revista Brasileira de Farmacognosia
    Article Open access 26 March 2022
  3. Cannabidiol and mitragynine exhibit differential interactive effects in the attenuation of paclitaxel-induced mechanical allodynia, acute antinociception, and schedule-controlled responding in mice

    Background

    For many chemotherapy patients peripheral neuropathy is a debilitating side effect. Mitragyna speciosa (kratom) contains the alkaloid...

    Yuma T. Ortiz, Joshua A. Bilbrey, ... Jenny L. Wilkerson in Pharmacological Reports
    Article 27 May 2023
  4. Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells

    Background

    Breast cancer (BC) is the most common malignancy and the leading cause of cancer-related death in women worldwide. Sirtuin inhibitors...

    Anna Wawruszak, Estera Okon, ... Jarogniew Luszczki in Pharmacological Reports
    Article Open access 28 July 2022
  5. Validation of a UV-Spectrophotometric Method for Quantitative Determination of Paclitaxel in a Targeted Delivery System Based on Poly(Lactic–Glycolic Acid) Copolymer Nanoparticles

    A UV spectrophotometric method for quantitative determination of paclitaxel in a conjugate of poly(lactic-glycolic acid) (PLGA) copolymer...

    M. B. Sokol, Yu. V. Sycheva, ... E. D. Nikol’skaya in Pharmaceutical Chemistry Journal
    Article 19 November 2020
  6. Preparation, Characterization, and In-Vitro Assessment of Calixarene Nanovesicles: A Supramolecular Based Nano-Carrier for Paclitaxel Drug Delivery

    In drug development field, active substance solubilization is among most important factors. Expanding significance is set on the role of drug...

    Jigar Raval, Riddhi Trivedi, Prajesh Prajapati in Pharmaceutical Chemistry Journal
    Article 25 September 2021
  7. Hyperthermal paclitaxel-bound albumin nanoparticles co-loaded with indocyanine green and hyaluronidase for treating pancreatic cancers

    Albumin nanoparticles have become an attractive cancer nanomedicine platform due to their pharmaceutical advantages. Recently, photothermal therapy...

    Sung Soo Kim, Hwang Kyung Kim, ... Yu Seok Youn in Archives of Pharmacal Research
    Article 17 August 2020
  8. Application of magnetic solid-phase extraction for sensitive determination of anticancer drugs in urine by means of diamino benzidine tetrachlorohydrate modified magnetic nanoparticles

    Background

    The analysis of drug active molecules and residues in the treatment of cancer is important for the sustainability of human life and...

    Emin Akyol, Halil İbrahim Ulusoy, ... Mustafa Soylak in Pharmacological Reports
    Article 25 February 2023
  9. AM1172 (a hydrolysis-resistant endocannabinoid analog that inhibits anandamide cellular uptake) reduces the viability of the various melanoma cells, but it exerts significant cytotoxic effects on healthy cells: an in vitro study based on isobolographic analysis

    Background

    Despite great advances in our understanding of the impact of cannabinoids on human organism, many of their properties still remain...

    Paweł Marzęda, Paula Wróblewska-Łuczka, ... Jarogniew J. Łuszczki in Pharmacological Reports
    Article Open access 29 November 2023
  10. Differential effect of LPS and paclitaxel on microglial functional phenotypes and circulating cytokines: the possible role of CX3CR1 and IL-4/10 in blocking persistent inflammation

    Neuroinflammation plays a role in cancer chemotherapy-induced chronic pain. Thus far, most studies have focused on neuroinflammation suppression....

    Joong-Won Ha, Min-Jung You, ... Min-Soo Kwon in Archives of Pharmacal Research
    Article 09 March 2019
  11. Novel method of measurement of in vitro drug uptake in OATP1B3 overexpressing cells in the presence of dextran

    Background

    In predictions about hepatic clearance (CL H ), a number of studies explored the role of albumin and transporters in drug uptake by liver...

    Anna Kowal-Chwast, Ewelina Gabor-Worwa, ... Kamil Kuś in Pharmacological Reports
    Article 26 March 2024
  12. Cytotoxic and Apoptosis-Inducing Activities of Iridium Complexes Bearing 2-Phenylimidazo[4,5-f][1,10]-Phenanthroline Derivatives in Human Cancer Cells

    In recent years, there has been growing exploration of organometallic transition metal complexes as promising options for develo** anticancer...

    Doğukan Mutlu, Cengiz İpek, ... Şevki Arslan in Pharmaceutical Chemistry Journal
    Article 01 May 2024
  13. Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress

    The molecular chaperone heat shock protein 90 (HSP90) regulates multiple crucial signalling pathways in cancer by driving the maturation of key...

    Yajun Liu, Chenyao Li, ... Shutao Tan in Archives of Pharmacal Research
    Article 17 April 2024
  14. PLANT BIOTECHNOLOGY

    Extensive research is underway worldwide on the production of active plant components from medicinal plants under controlled, reproducible conditions...
    Éva Szöke, Ágnes Kéry, Éva Lemberkovics in From Herbs to Healing
    Chapter 2023
  15. Agonisten und Antagonisten für nucleäre Rezeptoren

    Bei aller Begeisterung über die Erfolge beim strukturbasierten Entwurf von Enzyminhibitoren darf nicht übersehen werden, dass weniger als die Hälfte...
    Gerhard Klebe in Wirkstoffdesign
    Chapter 2023
  16. Targeted Molecular Therapeutics for Pulmonary Diseases: Addressing the Need for Precise Drug Delivery

    Respiratory diseases are a major concern in public health, impacting a large population worldwide. Despite the availability of therapies that...
    Simone Carneiro, Joschka T. Müller, Olivia M. Merkel in Drug Delivery and Targeting
    Chapter 2024
  17. Sensitivity Analysis for Restricted Mean Survival Time When Survival Curves Have Divergent Tails

    New immunotherapy methods are being developed to provide cancer patients with survival benefit. The tail effect of immuno-oncology (IO) therapy...

    Kentaro Ueno, Satoshi Morita in Therapeutic Innovation & Regulatory Science
    Article 03 January 2023
  18. Mirvetuximab soravtansine in folate receptor alpha-positive, platinum-resistant ovarian cancers: a profile of its use

    Mirvetuximab soravtansine (Elahere TM ), an antibody-drug conjugate carrying a maytansinoid payload targeting folate receptor alpha (FRα), is a...

    Simon Fung, Yahiya Y. Syed in Drugs & Therapy Perspectives
    Article 01 February 2024
  19. Anti-angiogenesis revisited: resha** the treatment landscape of advanced non-small cell lung cancer

    Although anti-angiogenic agents have been of limited use in the treatment of non-small cell lung cancer (NSCLC) until recently, further roles for the...

    Sun Ha Choi, Seung Soo Yoo, ... Jae Yong Park in Archives of Pharmacal Research
    Article 21 April 2022
  20. Creation of a Model of a Complex Delivery Nanosystem Containing a Tyrosine Kinase Inhibitor and a Photosensitizer

    The aim of this work was to construct complex delivery systems for the well-known hydrophobic inhibitor of tyrosine kinases, Gefitinib, and the...

    E. V. Sanarova, A. V. Lantsova, ... N. L. Solov’eva in Pharmaceutical Chemistry Journal
    Article 01 October 2023
Did you find what you were looking for? Share feedback.